To assess the contact allergic potential of sensitizers, an
in vitro predictive model was developed. First of all, guinea pigs were sensitized by 1-chloro-2-4-dinitrobenzene (DNCB), and lymph node cells from sensitized and control guinea pigs were cultured in the presence of DNCB, 2, 4-dinitrobenzene sulfonic acid sodium salt (DNBS), DNCB plus epidermal cell (DNCB+EC), DNBS+EC and epidermal cell modified hapten (dinitrophenyl-EC, DNP-EC) at 3×10
5, 5×10
5 and 8×10
5 cells/well, respectively. Lymphocyte blastogenesis responses were assessed by uptake of
3H-thymidine.
The results indicated that lymphocytes from sensitized guinea pigs responded to the foregoing antigens
in vitro to a greater degree than those from control guinea pigs and the blastogenesis response by DNBS was the highest among the challenges of DNBS, DNCB, DNCB+EC, DNBS+EC and DNP-EC. When the number of lymphocytes was sufficient, the blastogenesis response of lymphocytes could be
in vitro challenged successfully not only by DNBS, DNCB+EC, DNBS+EC and DNP-EC, but also DNCB alone. There was a cross sensitivity between DNCB and DNBS for
in vivo and
in vitro challenges. Moreover, significant relationships were observed between lymphocyte blastogenesis response and doses of DNBS used
in vitro assay at 5×10
5 and 8×10
5 cells/well.
The results indicate that this assay is an useful
in vitro predictive model of contact sensitivity and cross sensitivity of sensitizers.
View full abstract